CSAT National Advisory Council Members Biographical Information

CSAT National Advisory Council Members Biographies

MEMBERS

EX OFFICIO MEMBERS

  • The Honorable Xavier Becerra, Acting Secretary, U.S. Department of Health and Human Services
  • Miriam E. Delphin-Rittmon, Ph.D., Assistant Secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration
  • David J. Smith, M.D., Acting Assistant Secretary of Defense for Health Affairs, U.S. Department of Defense
  • George F. Koob, Ph.D., Director, National Institute on Alcohol Abuse and Alcoholism
  • Nora D. Volkow, M.D., National Institute on Drug Abuse​
  • The Honorable Denis Richard McDonough, Secretary, Veterans Affairs

Dianne L. Clarke, Ph.D.
Dianne Clarke, Ph.D. is the Chief Executive Officer of Operation PAR, Inc. and has more than 40 years of experience in the field of substance use disorder treatment As one of the original individuals to be certified as an Addiction Professional in Florida, Dr. Clarke has experience in all phases of substance use treatment for both adolescents and adults including; detoxification , residential treatment and all levels of outpatient treatment to include medication assisted treatment. Dr. Clarke is also one of the first individuals certified by the Florida Certification Board as a Telehealth Practitioner. Dr. Clarke is responsible for the operational activities for comprehensive behavioral health services for more than 50 programs in seven counties in Florida. Dr. Clarke is an Executive Board Member of the Florida Behavioral Health Association, Co-Chair of the Pinellas County Opiate Task Force, and Executive Board Member of the Florida Juvenile Justice Association.

Wesley L. Geminn, PharmD, BCPP
Wesley L. Geminn, PharmD, BCPP, is the Chief Pharmacist and SOTA Authority for the Tennessee Department of Mental Health and Substance Abuse Services' Division of Clinical Leadership. Dr. Geminn graduated from the University of Tennessee College of Pharmacy and completed a post-graduate residency in managed care and psychiatry with the Tennessee Department of Mental Health and Substance Abuse Services. He is currently board-certified in psychiatry by the Board of Pharmaceutical Specialties.

Belinda M. Greenfield, Ph.D.
Belinda M. Greenfield, Ph.D., currently serves as the Administrator for Forest Recovery & Psychiatric Group, overseeing SUD outpatient and Mental Health outpatient clinics in New Jersey. She is an Associate Adjunct Professor with Hunter College, City University of New York, where she teaches a variety of graduate counseling courses. Dr. Greenfield worked for over 22 years with New York State Office of Addiction Services and Supports (OASAS), and from 2006-2022 served as the NY State Opioid Treatment Authority (SOTA) where she provided regulatory and policy oversight for statewide Opioid Treatment Program services, comprised of 108 OTPs serving over 43,000 patients. Her national experience includes establishing and serving 3 terms as the President of the Opioid Treatment Network (OTN), a subcommittee of the National Treatment Network (NTN) under the organizational structure of the National Association of State Alcohol and Substance Abuse Directors (NASADAD).  She also provides consulting services, and is a Peer Reviewer for a number of federal government agencies. Dr. Greenfield has over 30 years’ experience in both SUD and psychiatric services, with emphases in Opioid Use Disorders treatment, use of medication assisted treatment to treat SUD, integrating SUD, mental health, and physical health services, streamlining organizational and clinical efficacy and efficiency across all SUD levels of care, and SUD state and federal regulatory expertise. 

Judith A. Martin, M.D.
Dr. Judith Martin is an addiction specialist who has worked with opioid-addicted patients and their families for over twenty years. She has provided training about methadone and buprenorphine treatment for addiction to physicians and clinic staff from many states. She is Medical Director for Substance Use Services at San Francisco's Community Behavioral Health Services. Her previous position was Medical Director at BAART Turk Street Clinic in San Francisco's Tenderloin district. Dr. Martin has been President of the California Society of Addiction Medicine (CSAM) and has been on the Executive Council and the Committee for the Treatment of Opiate Dependence of that organization. She has also participated in the National Institute of Drug Abuse (NIDA)'s Clinical Trials Network (CTN) on multi-site research studies of treatment of opioid and cocaine use disorders.

Charisse Evonne Peoples, Ph.D.
Charisse Evonne Peoples, Ph.D., is a licensed psychologist with experience in providing psychological evaluation and therapeutic services for adults and children of all ages. She was pivotal in implementing evidence-based practices of core correctional intervention strategies, including Motivational Interviewing and Cognitive Behavioral Intervention techniques, to reduce recidivism and relapse rates for those in the criminal justice system in Washington, DC. Dr. Peoples has expertise in both Criminal Justice and African American Minority Population.

Eva Petoskey, M.S.
Ms. Eva Petoskey has over 38 years of experience working with tribal communities throughout the Great Lakes region on issues related to wellness, education, evaluation and culture. Since 2007, Ms. Petoskey has served as the Program Director for the Inter-Tribal Council of Michigan’s Anishnaabek Healing Circle Access to Recovery, a large statewide collaborative involving the twelve federally recognized tribes in Michigan. The project provides treatment and recovery support services for over 1500 tribal youth and adults each year. Prior to this appointment, she operated a consulting business specializing in community–based research and evaluation services for tribes and Indian organizations for over 20 years. She has extensive experience in developing and implementing evaluation plans that involve multiple community sites, the management of follow-up interviews, client tracking, data storage, human subjects, GPRA collection, collaboration with cross-site evaluation efforts, training local data collection staff, and reporting evaluation findings to local stakeholders. Ms. Petoskey has created innovative culturally based evaluation approaches and instruments and she is the author of a web based Cultural Assessment Instrument utilized by Michigan Tribal treatment providers. Ms. Petoskey is a founding member of the First American Prevention Center, a tribally-based organization that has taken a leadership role nationwide in developing culturally-based curriculum and training services for Indian Tribes and organizations. She is the author or the Red Cliff Wellness Curriculum, a culturally based substance abuse prevention and community empowerment model that has been used in over 130 schools and communities in the U.S. and Canada. The Red Cliff Wellness is one of the few tribally developed model programs on the National Registry of Evidence Based Programs and Practices (NREPP). She has worked as a Senior Planner for the Minnesota Department of Human Services, Chemical Dependency Division, where she was responsible for monitoring and evaluating a State grant program that made federal block grant dollars available to Minnesota Tribes for substance abuse services. She has also worked at the Minnesota Indian Women’s Resource Center, the University of Minnesota, and the Great Lakes Inter-Tribal Council of Wisconsin. Ms. Petoskey is co-author of articles related to engaging communities in change: Prevention Through Empowerment in a Native American Community, Drugs and Society, Vol. 12, No 1/2, 1998, pp. 147-162; Strategies and Tactics of Program Evaluation: Implementation Issues, Center for Substance Abuse Prevention, 1999. She has authored numerous outcome evaluation reports. Ms. Petoskey is an enrolled member of the Grand Traverse Band of Ottawa and Chippewa Indians and served on the Tribal Council of the Grand Traverse Band for six years, four years as the Vice-Chairperson She has a long standing commitment to living her life based on Anishnaabek values.

A. Kenison Roy III, M.D., DFASAM, DLFAPA
Dr. Roy is founder and Chief Medical Officer of Avenues Recovery - New Orleans, a multi-level addiction treatment system in the private sector, in Metairie, LA (New Orleans area). He has had a successful adult addiction and private psychiatric practice for over 20 years. Dr. Roy is Clinical Associate Professor of Psychiatry at Tulane and LSU Schools of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Distinguished Fellow of the American Society of Addiction Medicine and is certified by the American Board of Psychiatry and Neurology, The American Board of Preventive Medicine in Addiction Medicine and the American Board of Addiction Medicine. He is a member of the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, The American College of Psychiatrists, the American Medical Association and the Louisiana Psychiatric Medical Association (LPMA) and is a Past President of LPMA. He has long held leadership positions in the American Society of Addiction Medicine (ASAM) and is currently a member of the Board of Directors representing Area 7.

Kenneth Stoller, M.D.
Dr. Stoller is an Associate Professor of Psychiatry and Behavioral Sciences and Director of the Johns Hopkins Broadway Center for Addiction (Johns Hopkins). His area of expertise is treatment and clinical research involving substance use problems and, in particular, the use of methadone and buprenorphine. His research interests have centered on cost issues as they relate to drug abuse and treatment, methods to enhance treatment adherence and retention, and co-occurring psychiatric, medical, pain, and substance use disorders. Published manuscripts and book chapters focus on the use of adaptive stepped care, treatment incentives, and integrated treatment of co-occurring disorders in a single setting. Through his work at Johns Hopkins Health Care, he has developed a related focus on fostering policies and initiatives applied in managed care settings to improve health outcomes and control costs, such as increasing the identification and treatment of substance use disorder and coordinating treatment of general somatic, mental health, and substance use disorders. More recently, since assuming the role of Director of the outpatient addiction treatment program for Johns Hopkins—particularly since his involvement with the American Association for the Treatment of Opioid Dependence, and as the representative on the Board of Directors for Maryland—he has refocused his academic work on the pursuit of increasing access to, and quality of, medication-assisted therapies in Baltimore, Maryland, and nationally. This work has received intense attention over the past two years, especially as it relates to coordinated care using opioid treatment programs as hubs of expertise and coordinating with community physicians prescribing medications for opioid use disorder. Dr. Stoller created and implemented the first known buprenorphine hub and spoke collaborative care model in the nation, and this is the subject of numerous presentations, webinars, and white papers.

Last Updated: 08/05/2022